Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
Open | $29.25 |
Close | - |
Volume / Avg. | 129.21K / 1.05M |
Day Range | $28.59 - $29.25 |
52 Wk Range | 19.50 - 45.58 |
Market Cap | $4.17B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 19.42% |
Days to Cover | 17.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
Immunovant has a consensus price target of $40.53.
The stock price for Immunovant (NASDAQ: IMVT) is $28.54 last updated September 23, 2024 at 11:02 AM EDT.
There are no upcoming dividends for Immunovant.
Immunovant’s Q2 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.